Showing results (81-90 of 96) with videos related to
Sort By:
Pageof 10
Journal of Medicinal Chemistry|March 23, 2010
Cyclic sulfones as novel P3-caps for hepatitis C virus NS3/4A (HCV NS3/4A) protease inhibitors: synthesis and evaluation of inhibitors with improved potency and pharmacokinetic profilesFrancisco Velázquez, Mousumi Sannigrahi, Frank Bennett, et al.Retina (Philadelphia, Pa.)|July 21, 2025
Comparison of Characteristics and Treatment Outcomes of Type 1 and Type 2 Myopic Choroidal Neovascularization After Anti-Vascular Endothelial Growth Factor TherapyTeck Boon Tew, Yi-Ting Hsieh, Mei-Chi Tsui, et al.Ophthalmology and Therapy|June 4, 2025
Early Anatomical and Functional Outcomes of Faricimab in Recalcitrant Neovascular Age-Related Macular Degeneration: A Retrospective Real-World Study in an East-Asian PopulationYen-An Lai, Mei-Chi Tsui, Shuo-Fang Cheng, et al.Journal of Medicinal Chemistry|February 7, 2009
Second-generation highly potent and selective inhibitors of the hepatitis C virus NS3 serine proteaseKevin X Chen, Latha Nair, Bancha Vibulbhan, et al.Journal of Medicinal Chemistry|April 18, 2009
Toward second generation hepatitis C virus NS3 serine protease inhibitors: discovery of novel P4 modified analogues with improved potency and pharmacokinetic profileAshok Arasappan, Angela I Padilla, Edwin Jao, et al.Journal of Medicinal Chemistry|December 24, 2008
Discovery and structure-activity relationship of P1-P3 ketoamide derived macrocyclic inhibitors of hepatitis C virus NS3 proteaseSrikanth Venkatraman, Francisco Velazquez, Wanli Wu, et al.Journal of Medicinal Chemistry|May 22, 2009
Toward the back-up of boceprevir (SCH 503034): discovery of new extended P4-capped ketoamide inhibitors of hepatitis C virus NS3 serine protease with improved potency and pharmacokinetic profilesStéphane L Bogen, Weidong Pan, Sumei Ruan, et al.Bioorganic & Medicinal Chemistry Letters|December 28, 2007
Discovery of novel orally active ureido NPY Y5 receptor antagonistsGuoqing Li, Andrew W Stamford, Ying Huang, et al.Bioorganic & Medicinal Chemistry Letters|March 23, 2010
The introduction of P4 substituted 1-methylcyclohexyl groups into Boceprevir: a change in direction in the search for a second generation HCV NS3 protease inhibitorFrank Bennett, Yuhua Huang, Siska Hendrata, et al.Bioorganic & Medicinal Chemistry Letters|April 3, 2009
The discovery of tropane derivatives as nociceptin receptor ligands for the management of cough and anxietyGinny D Ho, John Anthes, Ana Bercovici, et al.Pageof 10